PSYCHODAL is indicated for the treatment of schizophrenia. PSYCHODAL is indicated for the treatment of moderate to severe manic episodes associated with bipolar disoders. PSYCHODAL is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe. Alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. PSYCHODAL is indicated for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intekkectual functioning or mental retardation diagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviors require pgarmacologic treatment. Pharmacological treatment should be an integral part of a more comprehensive treatment programme, including psychosocial and educational intervention. It is recommended that risperidone be prescribed by a specialist in child neurology and child and adolescent psychiatry or physicians well familiar with the treatment of conduct disorder of children and adolescents.